Biotechnology
Filter News
Found 46,201 articles
-
6 Months After Pfizer Cuts Neuroscience Development, Adds $600 Million to Venture Arm with 25% Sl...
6/6/2018
Pfizer is now throwing an additional $600 million into its venture capital fund, with a quarter of it earmarked for neuroscience research investments. -
Actor, director and advocate Rob Reiner opened the third day of the 2018 BIO International Convention.
-
Metracrine, based in San Diego, completed a Series C financing round worth $65 million.
-
Axovant Sciences, one of Vivek Ramaswamy’s biotech startups, is taking another shot, this time at Parkinson’s disease.
-
There are several recent announcements of German companies opening laboratories in the U.S.
-
The secret group within Amazon working on a series of bold projects is starting to become a little less secret.
-
Unity Biotechnology has raised $222 million in venture capital, raised $85 million in an initial public offering (IPO) in May, and has a value of $700 million. All without having a product to sell.
-
Alkermes, received a $50 million milestone payment from Biogen. The payment occurred after Biogen reviewed preliminary gastrointestinal tolerability data from an ongoing Phase III clinical trial for MS.
-
South San Francisco-based Senti Biosciences is getting a new Chief Financial Officer and Chief Business Officer. Former Sangamo Therapeutics Senior Vice President and Chief Business Officer Curt Herberts will join Senti later this month.
-
Scientific Article by Kadimastem Regarding Its Cell-Based Treatment for ALS Published by a Prestigious Cell Therapy Scientific Journal
6/6/2018
The article describes the comprehensive scientific research of the company's flagship product, AstroRx®, which is the foundation of the clinical trial the company is currently conducting in ALS patients
-
Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T.
6/6/2018
Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 third quarter results Tuesday, June 12, 2018, at 8:30 AM E.T.
-
Synthego Launches Engineered Cells Product Portfolio as Next Step in Delivering Genome Engineering Access to All Scientists
6/6/2018
Engineered Cells single-click ordering and knockout guarantee removes barriers to world-class CRISPR results
-
nference Raises $11 Million to Further Develop its Artificial Intelligence Software Platform that Synthesizes the World’s Biomedical Knowledge
6/6/2018
Company expands operations and introduces world-class advisory board
-
Oxford BioMedica and Axovant Sciences enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease
6/6/2018
~ Conference call for analysts to be held at 2:30pm BST / 9:30am ET (see details below)
-
The BIO International Convention Begins Day Three with Keynote Speech from Actor, Director and Advocate Rob Reiner
6/6/2018
Wednesday programming will emphasize the patient and the role of the biotech industry in delivering care.
-
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine® (sargramostim) for the Treatment of Acute Radiation Syndrome
6/6/2018
Improves survival when initiated 48 hours after radiation exposure
-
CicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 Meeting
6/6/2018
CicloMed LLC, today announced the presentation of preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), its anti-cancer agent currently in Phase I clinical trials.
-
South Dakota Governor Dennis Daugaard Presented BIO Lifetime Champion Award
6/6/2018
The Biotechnology Innovation Organization (BIO) presented South Dakota Governor Dennis Daugaard with a Lifetime Champion Award
-
BIO Presents the Henri A. Termeer Biotechnology Visionary Award to Gates Foundation’s Dr. Sue Desmond-Hellmann
6/6/2018
The Biotechnology Innovation Organization (BIO) is pleased to announce the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation.
-
Shire launches screen responsibly, an eyelove® initiative dedicated to prioritizing eye health in a screen-saturated world
6/6/2018
Shire plc (LSE: SHP, NASDAQ: SHPG) announced the launch of screen responsibly, its new educational initiative about the intersection between our screen use and eye health.